Myriad Genetics, Inc. (MYGN)
NASDAQ: MYGN · Real-Time Price · USD
5.88
+0.45 (8.29%)
At close: Jun 26, 2026, 4:00 PM EDT
5.71
-0.17 (-2.89%)
After-hours: Jun 26, 2026, 7:38 PM EDT
Myriad Genetics Stock Forecast
Stock Price Forecast
The 6 analysts with 12-month price forecasts for Myriad Genetics stock have an average target of 7.33, with a low estimate of 5.50 and a high estimate of 10. The average target predicts an increase of 24.66% from the current stock price of 5.88.
Analyst Consensus: Hold
* Price targets were last updated on May 12, 2026.
Analyst Ratings
The average analyst rating for Myriad Genetics stock from 9 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 2 | 2 | 2 | 1 | 1 | 1 |
| Hold | 7 | 7 | 7 | 7 | 6 | 5 |
| Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Strong Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Total | 12 | 12 | 12 | 11 | 10 | 9 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Piper Sandler | Piper Sandler | Buy Maintains $8.5 | Buy | Maintains | $8.5 | +44.56% | May 12, 2026 |
| Bank of America Securities | Bank of America Securities | Sell Maintains n/a | Sell | Maintains | n/a | n/a | May 7, 2026 |
Unknown Analyst Guggenheim No rating | Guggenheim | Hold Maintains n/a | Hold | Maintains | n/a | n/a | May 7, 2026 |
| Wells Fargo | Wells Fargo | Hold Maintains $6 → $5.5 | Hold | Maintains | $6 → $5.5 | -6.46% | May 6, 2026 |
| Craig-Hallum | Craig-Hallum | Buy Reiterates $10 | Buy | Reiterates | $10 | +70.07% | May 6, 2026 |
Financial Forecast
Revenue This Year
863.56M
from 824.50M
Increased by 4.74%
Revenue Next Year
915.82M
from 863.56M
Increased by 6.05%
EPS This Year
0.05
from 0.06
Decreased by -20.37%
EPS Next Year
0.15
from 0.05
Increased by 216.26%
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 870.5M | 943.2M | |
| Avg | 863.6M | 915.8M | |
| Low | 859.2M | 894.2M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 5.6% | 9.2% | |
| Avg | 4.7% | 6.1% | |
| Low | 4.2% | 3.5% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 0.09 | 0.33 | |
| Avg | 0.05 | 0.15 | |
| Low | -0.06 | 0.04 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 50.0% | 590.7% | |
| Avg | -20.4% | 216.3% | |
| Low | - | -16.3% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.